Modern product engineering under clean room conditions for the manufacturing of plastic components for medical technology is carried out at Medi-Globe’s new production facility in Neuhaus-Schierschnitz, Germany. This is an important step to supply future markets in the field of medical technology and to strengthen the performance of the company.

The reason for setting up a larger production unit was the increased demand for the existing products and the need to install production technology for new projects. Customers currently benefit from brand new silicon (LSR one and two components) and thermoplastic injection moulding capacity with the option of insert moulding and 2K components.

The production area at the new location is enlarged to nearly 2,000m² whereas the clean room production area (ISO 7) has been enlarged to approximately 220m². Thus plastic components with a typical weight of below 1g and 100g can be produced from medical-grade thermoplastics and elastomeres.

Medi-Globe CardioPlast manufactures in its factory one-cavity and multi-cavity moulds as well as moulds for LSR and insert moulding.

Medi-Globe CardioPlast operates the factory under ISO 13485 and has long since implemented the US standards for Good Manufacturing Practice (GMP).

The design of a device has become particularly important over the past years; Medi-Globe CardioPlast sets new standards in this part of production. Esthetics, haptic and ergonomics have to be in balance with the product and signal the quality of the product. The combination of these aspects shows the increasing demand of specific products by customers.

“We detect frequently that, beside a perfect functionality and a high quality, the design of the product is more and more important for selling products,” explains Oliver-Marc Rados, CEO of Medi-Globe CardioPlast. “For this reason we support our customers in finding a successful product design in the phase of product development.”

In diagnostical and treating sectors, single-use products for medical use, called disposables, have to meet ever stricter requirements in the field of design. For a few years device medicine has needed more and more high performance in product design. Modern 3D techniques allow freeform surfaces to be realised inexpensively.

Besides insert mouldings of plastics, the product portfolio is enlarged by tubes (one and multi-luminated) for medical engineering, prototype manufactoring, ETO sterilisation of gas and assembly performance. These are produced within the Medi-Globe Group.

Medi-Globe CardioPlast will present its products and services at Medtec Europe – a trade show for suppliers of device medicine – from 23-25 March 2010.